Table of Contents Author Guidelines Submit a Manuscript
International Journal of Breast Cancer
Volume 2012, Article ID 453985, 8 pages
http://dx.doi.org/10.1155/2012/453985
Research Article

Racial Differences in the Use of Adjuvant Chemotherapy for Breast Cancer in a Large Urban Integrated Health System

1Department of Oncology, Karmanos Cancer Institute, Wayne State University, 4100 John Road, 4221 HWCRC Detroit, MI 48201, USA
2Population Studies and Disparities Research Program, Karmanos Cancer Institute, Wayne State University, Detroit, MI 48201, USA
3Department of Public Health Sciences, Henry Ford Health Systems, Detroit, MI 48202, USA
4Department of Family Medicine and Public Health Sciences, Wayne State University, Detroit, MI 48201, USA
5Wayne State University School of Medicine, Detroit, MI 48201, USA

Received 6 January 2012; Revised 18 March 2012; Accepted 19 March 2012

Academic Editor: Wonshik Han

Copyright © 2012 Michael S. Simon et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. L. X. Clegg, F. P. Li, B. F. Hankey, K. Chu, and B. K. Edwards, “Cancer survival among US whites and minorities: a SEER (Surveillance, Epidemiology, and End Results) Program population-based study,” Archives of Internal Medicine, vol. 162, no. 17, pp. 1985–1993, 2002. View at Publisher · View at Google Scholar · View at Scopus
  2. C. I. Li, K. E. Malone, and J. R. Daling, “Differences in breast cancer stage, treatment, and survival by race and ethnicity,” Archives of Internal Medicine, vol. 163, no. 1, pp. 49–56, 2003. View at Publisher · View at Google Scholar · View at Scopus
  3. A. Ghafoor, A. Jemal, E. Ward, V. Cokkinides, R. Smith, and M. Thun, “Trends in breast cancer by race and ethnicity,” Ca-A Cancer Journal for Clinicians, vol. 53, no. 6, pp. 342–355, 2003. View at Google Scholar · View at Scopus
  4. E. Ward, A. Jemal, V. Cokkinides et al., “Cancer disparities by race/ethnicity and socioeconomic status,” Ca-A Cancer Journal for Clinicians, vol. 54, no. 2, pp. 78–93, 2004. View at Google Scholar · View at Scopus
  5. M. S. Simon, M. Banerjee, H. Crossley-May, F. D. Vigneau, A. M. Noone, and K. Schwartz, “Racial differences in breast cancer survival in the Detroit Metropolitan area,” Breast Cancer Research and Treatment, vol. 97, no. 2, pp. 149–155, 2006. View at Publisher · View at Google Scholar · View at Scopus
  6. D. Hershman, R. McBride, J. S. Jacobson et al., “Racial disparities in treatment and survival among women with early-stage breast cancer,” Journal of Clinical Oncology, vol. 23, no. 27, pp. 6639–6646, 2005. View at Publisher · View at Google Scholar · View at Scopus
  7. V. Grann, A. B. Troxel, N. Zojwalla, D. Hershman, S. A. Glied, and J. S. Jacobson, “Regional and racial disparities in breast cancer-specific mortality,” Social Science and Medicine, vol. 62, no. 2, pp. 337–347, 2006. View at Publisher · View at Google Scholar · View at Scopus
  8. D. L. Hershman, J. M. Unger, W. E. Barlow et al., “Treatment quality and outcomes of African American versus white breast cancer patients: retrospective analysis of southwest oncology studies S8814/S8897,” Journal of Clinical Oncology, vol. 27, no. 13, pp. 2157–2162, 2009. View at Publisher · View at Google Scholar · View at Scopus
  9. M. J. Lund, K. F. Trivers, P. L. Porter et al., “Race and triple negative threats to breast cancer survival: a population-based study in Atlanta, GA,” Breast Cancer Research and Treatment, vol. 113, no. 2, pp. 357–370, 2009. View at Publisher · View at Google Scholar · View at Scopus
  10. D. Braithwaite, C. M. Tammemagi, D. H. Moore et al., “Hypertension is an independent predictor of survival disparity between African-American and white breast cancer patients,” International Journal of Cancer, vol. 124, no. 5, pp. 1213–1219, 2009. View at Publisher · View at Google Scholar · View at Scopus
  11. C. M. Tammemagi, D. Nerenz, C. Neslund-Dudas, C. Feldkamp, and D. Nathanson, “Comorbidity and survival disparities among black and white patients with breast cancer,” Journal of the American Medical Association, vol. 294, no. 14, pp. 1765–1772, 2005. View at Publisher · View at Google Scholar · View at Scopus
  12. N. Howlader, A. M. Noone, M. Krapcho et al., Eds., SEER Cancer Statistics Review 1975–2008, National Cancer Institute, Bethesda, Md, USA, 2011.
  13. S. Glück and T. Mamounas, “Improving outcomes in early-stage breast cancer,” Oncology (Williston Park, N.Y.), vol. 24, no. 11, supplement 4, pp. 1–15, 2010. View at Google Scholar · View at Scopus
  14. R. W. Carlson, “NCCN breast cancer clinical practice guidelines in oncology: an update,” JNCCN: Journal of the National Comprehensive Cancer Network, vol. 1, supplement 1, pp. S61–S63, 2003. View at Google Scholar · View at Scopus
  15. J. J. Griggs, M. E. S. Sorbero, A. T. Stark, S. E. Heininger, and A. W. Dick, “Racial disparity in the dose and dose intensity of breast cancer adjuvant chemotherapy,” Breast Cancer Research and Treatment, vol. 81, no. 1, pp. 21–31, 2003. View at Publisher · View at Google Scholar · View at Scopus
  16. W. Du and M. S. Simon, “Racial disparities in treatment and survival of women with stage I-III breast cancer at a large academic medical center in metropolitan Detroit,” Breast Cancer Research and Treatment, vol. 91, no. 3, pp. 243–248, 2005. View at Publisher · View at Google Scholar · View at Scopus
  17. C. J. Bradley, C. W. Given, and C. Roberts, “Race, socioeconomic status, and breast cancer treatment and survival,” Journal of the National Cancer Institute, vol. 94, no. 7, pp. 490–496, 2002. View at Google Scholar · View at Scopus
  18. T. E. Byers, H. J. Wolf, K. R. Bauer et al., “The impact of socioeconomic status on survival after cancer in the United States: findings from the National Program of Cancer Registries patterns of care study,” Cancer, vol. 113, no. 3, pp. 582–591, 2008. View at Publisher · View at Google Scholar · View at Scopus
  19. J. J. Griggs, E. Culakova, M. E. S. Sorbero et al., “Social and racial differences in selection of breast cancer adjuvant chemotherapy regimens,” Journal of Clinical Oncology, vol. 25, no. 18, pp. 2522–2527, 2007. View at Publisher · View at Google Scholar · View at Scopus
  20. D. Hershman, M. Weinberg, Z. Rosner et al., “Ethnic neutropenia and treatment delay in African American women undergoing chemotherapy for early-stage breast cancer,” Journal of the National Cancer Institute, vol. 95, no. 20, pp. 1545–1548, 2003. View at Google Scholar · View at Scopus
  21. S. S. Gorin, J. E. Heck, B. Cheng, and S. J. Smith, “Delays in breast cancer diagnosis and treatment by racial/ethnic group,” Archives of Internal Medicine, vol. 166, no. 20, pp. 2244–2252, 2006. View at Publisher · View at Google Scholar · View at Scopus
  22. National Comprehensive Cancer Network (NCCN), NCCN Clinical Practice Guidelines in Oncology: Breast Cancer, Version 1, National Comprehensive Cancer Network, 2003.
  23. National Comprehensive Cancer Network (NCCN), NCCN Clinical Practice Guidelines in Oncology: Breast Cancer, Version 1, National Comprehensive Cancer Network, 2000.
  24. R. W. Carlson, L. J. Goldstein, W. J. Gradishar et al., “NCCN Breast Cancer Practice Guidelines. The National Comprehensive Cancer Network,” Oncology, vol. 10, no. 11, pp. 47–75, 1996. View at Google Scholar · View at Scopus
  25. M. E. Charlson, P. Pompei, K. L. Ales, and C. R. MacKenzie, “A new method of classifying prognostic comorbidity in longitudinal studies: development and validation,” Journal of Chronic Diseases, vol. 40, no. 5, pp. 373–383, 1987. View at Google Scholar · View at Scopus
  26. R. A. Deyo, D. C. Cherkin, and M. A. Ciol, “Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases,” Journal of Clinical Epidemiology, vol. 45, no. 6, pp. 613–619, 1992. View at Publisher · View at Google Scholar · View at Scopus
  27. A. C. Klassen, F. C. Curriero, J. H. Hong et al., “The role of area-level influences on prostate cancer grade and stage at diagnosis,” Preventive Medicine, vol. 39, no. 3, pp. 441–448, 2004. View at Publisher · View at Google Scholar · View at Scopus
  28. M. Banerjee, J. George, C. Yee, W. Hryniuk, and K. Schwartz, “Disentangling the effects of race on breast cancer treatment,” Cancer, vol. 110, no. 10, pp. 2169–2177, 2007. View at Publisher · View at Google Scholar · View at Scopus